STEM CELLS Translational Medicine

STEM CELLS Translational Medicine (SCTM), founded in 2012, is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices. The potential of stem cells therapies and regenerative medicine is both provocative and powerful, offering the distinct possibility of eventually repairing or replacing tissues damaged from disease, including certain cancers. By helping speed expertly executed translations of emerging lab discoveries into legitimate clinical trials and bedside application, STEM CELLS Translational Medicine ultimately will improve patient outcomes.